Te­va sees room for growth with FDA com­mu­ni­ca­tions and com­plex gener­ics, COO says

While em­broiled in le­gal bat­tles, gener­ic drug gi­ant Te­va Phar­ma­ceu­ti­cals is hop­ing to turn a cor­ner with the FDA in im­prov­ing their com­mu­ni­ca­tions and fo­cus …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.